← SynDRA
PITAVASTATIN
SynDRA canonical compound SYN0023604 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HMGCR |
| Mechanism of action | HMGCR inhibitor |
| Indication | hyperlipidemia |
| Disease area | endocrinology |
All known targets
- HMGCR
- APOA1
- CYP2C8
- NR4A2
- RXRA
Mechanisms of action (all sources)
- HMGCR INHIBITOR
- HMG-CoA reductase inhibitor
Drug classes
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- HMG-CoA Reductase Inhibitor
- Anticholesteremic Agents
- Antimetabolites
- Enzyme Inhibitors
- Hypolipidemic Agents
- Lipid Regulating Agents
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- nisvastatin
- itavastatin
- pitavastatin calcium hydrate
- pitavastatin calcium
- livalo
- Pitavastatine
- Pitavastatina
- NSC-760423
- Pitavastatin component of k-924 pivastatin
- PITAVASTATIN CALCIUM
- Livalo
- Pitavastatin hemicalcium
- NK-104
- Nisvastatin
- UNII-IYD54XEG3W
- Flovas
- IYD54XEG3W
- 2C25H23FNO4Ca
- CHEBI:71258
- NK 104 (acid)
- Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
- AK-50694
- Itavastatin calcium
- Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt
- Pitavastatin calcium (JAN)
- Alipza
- Livazo
- P 872441
- 6-Heptenoic acid,
- Itavastatin
- Pitavastatin [INN]
- Pitavastatin calcium
- (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
- CHEBI:32020
- M5681Q5F9P
- (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
- NSC 760423
- (3R,5S,6E)-7-(2-Cyclopropyl-4-(p-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
Reported adverse events
- Constipation
- Hypersensitivity
- Myalgia
- Myopathy
- Pain in extremity
- Rhabdomyolysis
- Virologic failure
- Back pain
- Pain
Look up PITAVASTATIN in the interactive SynDRA portal →